Amicus Therapeutics
Amicus Therapuetics is a biotechnology company developing therapies to cure rare diseases.
All edits by Seth Rhoades
Edits on 30 Apr, 2019
Seth Rhoades
Edits made to:
Article (+15/-15 characters)
Article
On May 13, 2004 Amicus Therapeutics completed their series B funding round with $31 million in funding from Canaan PartnersCanaan Partners (lead investor), Radius Venture Partners, New Enterprise Associates, Frazier Healthcare Partners, and CHL Medical Partners.
Find more companies like Amicus Therapeutics
Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
By using this site, you agree to our Terms of Service.